"Mycosis Fungoides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
| Descriptor ID |
D009182
|
| MeSH Number(s) |
C04.557.386.480.750.800.550 C15.604.515.569.480.750.800.550 C20.683.515.761.480.750.800.550
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycosis Fungoides".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Mycosis Fungoides [C04.557.386.480.750.800.550]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Mycosis Fungoides [C15.604.515.569.480.750.800.550]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Mycosis Fungoides [C20.683.515.761.480.750.800.550]
Below are MeSH descriptors whose meaning is more specific than "Mycosis Fungoides".
This graph shows the total number of publications written about "Mycosis Fungoides" by people in this website by year, and whether "Mycosis Fungoides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycosis Fungoides" by people in Profiles.
-
Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique. J Am Acad Dermatol. 2021 Jul; 85(1):121-127.
-
Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Ann Diagn Pathol. 2019 Dec; 43:151404.
-
Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and S?zary syndrome. Br J Haematol. 2019 07; 186(2):377-379.
-
Early morphea simulating patch-stage mycosis fungoides. Am J Dermatopathol. 2015 May; 37(5):409-12.
-
Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and S?zary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):98-105.
-
Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. J Am Acad Dermatol. 2014 Jun; 70(6):993-1001.
-
The expression of ALK in mycosis fungoides, stage IA. J Cutan Pathol. 2013 Mar; 40(3):348-50.
-
Lymphoepithelioma-like carcinoma in a patient with mycosis fungoides. J Drugs Dermatol. 2012 May; 11(5):663-4.
-
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood. 2012 Jan 12; 119(2):355-63.
-
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O6-methylguanine-DNA methyltransferase and mismatch repair proteins. Clin Cancer Res. 2011 Sep 01; 17(17):5748-54.